Publications by authors named "C Dacquet"

Background And Purpose: Selective peroxisome proliferator-activated receptors (PPARs) are widely used to treat metabolic complications; however, the limited effect of PPARα agonists on glucose metabolism and the adverse effects associated with selective PPARγ activators have stimulated the development of novel pan-PPAR agonists to treat metabolic disorders. Here, we synthesized a new prenylated benzopyran (BP-2) and evaluated its PPAR-activating properties, anti-inflammatory effects and impact on metabolic derangements.

Experimental Approach: BP-2 was used in transactivation assays to evaluate its agonism to PPARα, PPARβ/δ and PPARγ.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers designed nitrogen heterocycles based on α-ethoxyphenylpropionic acid derivatives to target PPARα/γ receptors for treating type 2 diabetes (T2D).
  • Among the compounds tested, 6-Benzoyl-benzothiazol-2-one demonstrated the best results after modifications, leading to a specific stereoisomer with an excellent in vitro pharmacological profile.
  • This compound was identified as a potent full PPARγ agonist and a weak partial agonist for PPARα, showing effectiveness in reducing triglycerides, glucose, and insulin levels in ob/ob mice without causing significant weight gain, classifying it as a selective PPARγ modulator (SPPARγM).
View Article and Find Full Text PDF

We describe the synthesis of 26 compounds, small polycerasoidol analogs, that are Lipinski's rule-of-five compliant. In order to confirm key structural features to activate PPARα and/or PPARγ, we have adopted structural modifications in the following parts: (i) the benzopyran core (hydrophobic nucleus) by benzopyran-4-one, dihydrobenzopyran or benzopyran-4-ol; (ii) the side chain at 2-position by shortening to C3, C4 and C5-carbons versus C-9-carbons of polycerasoidol; (iii) the carboxylic group (polar head) by oxygenated groups (hydroxyl, acetoxy, epoxide, ester, aldehyde) or non-oxygenated motifs (allyl and alkyl). Benzopyran-4-ones 6, 12, 13 and 17 as well as dihydrobenzopyrans 22, 24 and 25 were able to activate hPPARα, whereas benzopyran-4-one (7) with C5-carbons in the side chain exhibited hPPARγ agonism.

View Article and Find Full Text PDF

Dual peroxisome proliferator-activated receptor-α/γ (PPARα/γ) agonists regulate both lipid and glucose homeostasis under different metabolic conditions and can exert anti-inflammatory activity. We investigated the potential dual PPARα/γ agonism of prenylated benzopyrans polycerasoidol () and polycerasoidin () and their derivatives for novel drug development. Nine semisynthetic derivatives were prepared from the natural polycerasoidol () and polycerasoidin (), which were evaluated for PPARα, -γ, -δ and retinoid X receptor-α activity in transactivation assays.

View Article and Find Full Text PDF

The rhythmic nature of insulin secretion over the 24h cycle in pancreatic islets has been mostly investigated using transcriptomics studies showing that modulation of insulin secretion over this cycle is achieved via distal stages of insulin secretion. We set out to measure β-cell exocytosis using in depth cell physiology techniques at several time points. In agreement with the activity and feeding pattern of nocturnal rodents, we find that C57/Bl6J islets in culture for 24h exhibit higher insulin secretion during the corresponding dark phase than in the light phase (Zeitgeber Time ZT20 and ZT8, respectively, in vivo).

View Article and Find Full Text PDF